Corbus Pharmaceuticals Holdings, Inc. (CRBP): Price and Financial Metrics
CRBP Stock Summary
- As for revenue growth, note that CRBP's revenue has grown -83.81% over the past 12 months; that beats the revenue growth of just 1.68% of US companies in our set.
- In terms of volatility of its share price, CRBP is more volatile than 96.69% of stocks we're observing.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CRBP comes in at -71.12% -- higher than that of just 3.24% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Corbus Pharmaceuticals Holdings Inc are NTLA, MTEM, XENE, RCUS, and CTMX.
- CRBP's SEC filings can be seen here. And to visit Corbus Pharmaceuticals Holdings Inc's official web site, go to www.corbuspharma.com.
CRBP Stock Price Chart Interactive Chart >
CRBP Price/Volume Stats
| Current price | $2.31 | 52-week high | $9.78 |
| Prev. close | $2.33 | 52-week low | $0.91 |
| Day low | $2.23 | Volume | 957,574 |
| Day high | $2.39 | Avg. volume | 19,060,652 |
| 50-day MA | $2.09 | Dividend yield | N/A |
| 200-day MA | $3.95 | Market Cap | 194.13M |
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Company Bio
Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. The company is based in Norwood, Massachusetts.
Latest CRBP News From Around the Web
Below are the latest news stories about Corbus Pharmaceuticals Holdings Inc that investors may wish to consider to help them evaluate CRBP as an investment opportunity.
4 Hot Small Cap Stocks: Corbus Pharmaceuticals (NASDAQ: CRBP) Medical Marijuana (OTC US: MJNA) Microvision (NASDAQ: MVIS) and Global Battery Metals (OTC US: REZZF) - Stocks News FeedIf January and February are a sign of things to come in 2021, traders and investors are going to make a lot of money this year. 4 hot small cap stocks on the move are Corbus Pharmaceuticals (NASDAQ: CRBP), Medical Marijuana (OTCMKTS: MJNA), Microvision (NASDAQ: MVIS), and Global Battery Metals (OTCMKTS: REZZF). HOW TO TRADE… Read More »4 Hot Small Cap Stocks: Corbus Pharmaceuticals (NASDAQ: CRBP) Medical Marijuana (OTC US: MJNA) Microvision (NASDAQ: MVIS) and Global Battery Metals (OTC US: REZZF) |
4 Hot Small Cap Stocks: Corbus Pharmaceuticals (NASDAQ: CRBP) Medical Marijuana (OTC US: MJNA) Microvision (NASDAQ: MVIS) and Global Battery Metals (OTC US: REZZF)Feb 11, 2021 (OTC PR WIRE via COMTEX) -- If January and February are a sign of things to come in 2021, traders and investors are going to make a lot of money… |
GW Deal With Jazz Spurs Pot Stock Wave, a Look at Smaller PlayersIt’s been a wild ride for GW Pharmaceuticals (NASDAQ:GWPH). Founded in 1998, it took 20 years for the cannabis-centered pharma firm to achieve its first FDA approval. That was for Sativex back in 2018, a sublingual spray consisting of a mixture of different cannabinoids, used to treat spasticity from multiple sclerosis. Later that same year, […] The post GW Deal With Jazz Spurs Pot Stock Wave, a Look at Smaller Players appeared first on Market Exclusive. |
Corbus Pharmaceuticals Holdings Inc. stock rises Wednesday, outperforms marketShares of Corbus Pharmaceuticals Holdings Inc. jumped 10.88% to $3.42 Wednesday, on what proved to be an all-around mixed trading session for the stock… |
The Week In Cannabis: Stocks Up By Double-Digits On Jazz Pharma's GWPH Acquisition, Potential Federal MovesCannabis stocks had one of their strongest weeks in history. Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) acquired GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) for $7.2 billion, or $6.7 billion excluding GW Pharma's cash. The price of $220 per ADS in cash and stock, with $200 in cash and $20 in Jazz shares, represents about 50.4% premium over the $146.25 per share at which GW Pharma had closed on Tuesday. “The Jazz Pharmaceutical acquisition of GW Pharmaceuticals for $7 billion shows just how much companies are willing to pay for cannabis assets," Green Market Report editor Debra Borchardt told Benzinga. "It seems the bear market for cannabis stocks is officially over as GW Pharma stock jumped over 50% on the news." Benzinga Cannabis content is now available in Spanish on El Planteo . Other ... |
CRBP Price Returns
| 1-mo | 3.59% |
| 3-mo | 73.68% |
| 6-mo | -75.03% |
| 1-year | -52.27% |
| 3-year | -67.46% |
| 5-year | 40.00% |
| YTD | 84.80% |
| 2020 | -77.11% |
| 2019 | -6.51% |
| 2018 | -17.75% |
| 2017 | -15.98% |
| 2016 | 412.12% |
Continue Researching CRBP
Here are a few links from around the web to help you further your research on Corbus Pharmaceuticals Holdings Inc's stock as an investment opportunity:Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Price | Nasdaq
Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Quote, History and News - Yahoo Finance
Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Price and Basic Information | MarketWatch
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Loading social stream, please wait...